Home  |  Contact

Cellosaurus YCMi001-B (CVCL_A9YX)

[Text version]
Cell line name YCMi001-B
Synonyms Del-iPSC-Epi6; HA patient iPSC
Accession CVCL_A9YX
Resource Identification Initiative To cite this cell line use: YCMi001-B (RRID:CVCL_A9YX)
Comments From: Yonsei University College of Medicine; Seoul; South Korea.
Population: Korean.
Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
Sequence variations
  • Mutation; HGNC; 3546; F8; Unexplicit; Ex8-22del; Zygosity=Hemizygous (PubMed=31105049; PubMed=32798916).
Disease Hemophilia A (NCIt: C27146)
Hemophilia A (ORDO: Orphanet_98878)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_A9YY (YCMi001-B-1)
Originate from same individual CVCL_ZB28 ! YCMi001-A
Sex of cell Male
Age at sampling 44Y
Category Induced pluripotent stem cell
Publications

PubMed=31105049; DOI=10.1016/j.stemcr.2019.04.016
Park C.-Y., Sung J.J., Cho S.-R., Kim J., Kim D.-W.
Universal correction of blood coagulation factor VIII in patient-derived induced pluripotent stem cells using CRISPR/Cas9.
Stem Cell Reports 12:1242-1249(2019)

PubMed=32798916; DOI=10.1016/j.scr.2020.101948
Sung J.J., Park S., Choi S.-H., Kim J., Cho M.S., Kim D.-W.
Generation of a gene edited hemophilia A patient-derived iPSC cell line, YCMi001-B-1, by targeted insertion of coagulation factor FVIII using CRISPR/Cas9.
Stem Cell Res. 48:101948-101948(2020)

Cross-references
Cell line databases/resources hPSCreg; YCMi001-B
Biological sample resources BioSamples; SAMEA7211857
Encyclopedic resources Wikidata; Q102115138
Entry history
Entry creation29-Oct-2020
Last entry update05-Oct-2023
Version number7